Cansortium Inventory: The Most Underappreciated Hashish Firm (OTCMKTS:CNTMF)

I’ve been doing lots of work within the hashish area just lately and have come throughout some very attention-grabbing and really low-cost alternatives. I’d wish to share one right here and probably some extra down the street. Typical microcap stuff applies – for small funds and PAs, trades round $25k/day, shows/supplies are usually not nice (though IR isn’t dangerous) and there may be one lone analyst who has written some reviews on the enterprise. Nevertheless, this is likely one of the quickest rising (non-Tier 1 MSO), most worthwhile, highest margin and most cost-effective hashish shares in the whole hashish universe. I additionally consider Cansortium Inc. (OTCQX:CNTMF) is at an inflection level the place we may see a fast improve in revenues/EBITDA from right here (which we’re already seeing as of Q1 and Q2) ensuing within the inventory buying and selling above $0.75/share throughout the subsequent yr or so. There was zero share value response after two file quarters to this point this yr, and the inventory at the moment trades at lower than 3.0x my estimate of subsequent yr’s EBITDA, with a powerful development runway and really engaging takeout potential.

Cansortium Inc. (quickly to be renamed ‘Fluent’) is a hashish firm that produces and sells medical hashish all through the US. The corporate’s core market is Florida the place they’re vertically built-in, partaking within the cultivation, processing, retail, and distribution of hashish. Its medical hashish merchandise are supplied in oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles. The corporate supplies its merchandise below the Fluent model title. As of Q2 2022, Cansortium operated 27 dispensaries in Florida, 3 in Pennsylvania, one in Texas and previously a develop operation in Michigan that they just lately exited given the tough pricing atmosphere within the state. Within the late 2010’s, Cansortium started promoting medical marijuana below the enterprise title Knox Medical with cultivation, processing and allotting services in Florida, Texas, Pennsylvania and Puerto Rico. The corporate re-branded to Cansortium in 2019 and launched the Fluent Hashish Care model alongside an IPO on the Canadian Securities Change the place they raised $56mm for growth and commenced cultivation at their Tampa facility. On the time, Cansortium had 10 dispensaries in Florida with plans to broaden to 30 (throughout 2019), whereas ending the yr having generated $29mm in revenues. Quick ahead to in the present day and Cansortium operates 31 complete dispensaries with projected 2022 revenues of $90-95mm. Cansortium could be very a lot a turnaround story that I consider is at the moment at an inflection level, having struggled below the burden of prior administration, over-expansion plans and incapacity to ship outcomes. Right this moment, on the again of latest administration efforts, operational enhancements, a rising medical market in Florida and extra managed growth plans, it is attainable we may see revenues and EBITDA considerably improve from right here.

These will increase are already underway as of Q1 and Q2 of this yr, the place Cansortium reported file quarterly revenues (and development), file adjusted EBITDA and constructive money from operations. As well as, they’re one of many solely hashish companies value mentioning that has NOT decreased steering or lowered estimates for the yr. In truth, FY22 steering could show to be conservative.

Cansortium has a couple of essential traits that make it a gorgeous funding within the area: precise scale in one of many strongest markets within the US, vertical integration, and money move positivity. Cansortium has two massive develop operations in Sweetwater and Tampa and has expanded their Florida cultivation operations from 26,000 sq. toes on the time of the IPO to 136,000 sq. toes in the present day. Moreover, the corporate is enterprise two initiatives to deliver its cultivation footprint up 250,000 sq. toes which ought to be accomplished in the course of the again half of this yr. Cansortium’s mixed manufacturing capability of each their Sweetwater and Tampa services is 200,000 grams of manufacturing per week (22,000 lbs.). The services owned by Cansortium are extremely environment friendly, using vertical develop operations and able to producing crop equal to a facility with 3x the sq. footage. Early on, Cansortium additionally entered into administration companies agreements for the funding and buildout of the services with payouts coming from money generated by the services. I consider that technique made lots of sense given the upfront capital wants for cultivation in addition to with the ability to faucet the experience of confirmed cultivators within the state. Now at scale, the corporate plans to finish the yr with 31-32 dispensaries within the state of Florida that are at the moment below building and importantly are usually not factored into the FY22 information. Though 85-90% of revenues are derived from Florida operations, CNTMF additionally has three dispensaries in Pennsylvania and a cultivation facility and retail dispensary in Texas, offering de minimis contribution to revenues. Though the PA dispensaries are considerably current builds, they’re in favorable places and supply a small chunk of revenues. Cansortium has additionally been rising their affected person depend in Texas, no small feat because the lone star state is likely one of the most restrictive in the whole US, neither legalizing medical or grownup use at this stage. Cansortium is certainly one of three license holders in Texas, has a 400k sq. ft cultivation facility connected to at least one retail dispensary, and will probably be able to pounce on any change in state legalization. Whereas administration talked about making a respectable run in Texas and serving to to alter the legislative atmosphere, it’s attainable that these belongings might be disposed of to fund additional growth in Florida and pay down debt.

It’s estimated per OMMU knowledge that Cansortium has round a 4% (and rising) share of the Florida medical market. OMMU and different sources will record Cansortium because the 6^th or 7^th largest participant, nevertheless I consider market share stats are a bit deceptive as gamers #3-5 have solely 1-2 extra dispensaries than Cansortium and just a few bps increased share of flower gross sales within the state. That’s to say that the hole isn’t extensive for Cansortium to maneuver up the market share ranks, particularly as they’re rising quicker than any of their friends at this stage. For instance, the low finish of the corporate’s FY22 information implies 38% income development yr over yr, considerably increased than all however a couple of of their friends. Shifting ahead, share features can proceed as Cansortium’s yields will improve from extra cultivation enhancements, manufacturing capability will improve, new dispensaries will probably be opened, and CNTMF is lastly producing sufficient stock to totally inventory cabinets.

From the This fall 2021 / Q1 2022 name:

Stock shipped in Florida was up 75% in March in comparison with this previous December, reflecting the best ranges of stock we have ever had. We have now loved constructing stock within the retailer vaults, whereas on the identical time, experiencing file gross sales. So we’re promoting extra and producing extra on the identical time. For perspective, final yr, we’d run out of flower at our dispensaries nearly day by day. And generally we’d not make it previous the mid-day earlier than operating out of flower. We merely didn’t have sufficient manufacturing capability to fulfill the demand in our shops and having flower is a key promoting level to draw sufferers by the door to buy every other merchandise. Right this moment, we’ve got an ample degree of flower and total provide for our 27 shops with Tampa and Sweetwater operating at max manufacturing.

Extra advantages to really having product embody with the ability to measure the gross sales cadence, run checks, promote sure manufacturers and usually handle stock higher. It is laborious to know what’s working while you don’t have sufficient product to promote. I consider the stock scenario has and can proceed to enhance shifting ahead and will assist CNTMF proceed to take share as Florida is an extremely massive untapped market with vital runway for development. Administration agrees.

From Q3 2021 name:

Okay. It is super. I feel that we have stated earlier than and I’ve stated earlier than to you, which is if it weren’t for the race for footprint that is happening in Florida, I’d not open one other retailer as a result of we’d — if we had been in a vacuum, we’d spend this yr maximizing our present retailer cabinets to understand what these retailer ceilings are. We have not but had — and even in the present day, haven’t but had the chance to take a retailer and have it at full strong stock all day lengthy day by day.

…so the quantity of market share is now beginning to be traded round slightly bit between us. However there are nonetheless extra legislative occasions apart from legalization. And I’ve spoken on this earlier than, I feel a reciprocity, which is a quite simple administrative quantity. If you consider the variety of cardholders from different states that come to Orlando, Miami, Tampa and Jacksonville, only a reciprocity measure, which might be an simply regulatory transfer, which may occur any time now.

…it might be a 30% gross sales improve throughout the board with out one new affected person. So there are regulatory initiatives that would occur in need of leisure that might dramatically improve Florida. Then there’s leisure. So I feel what I am seeing is the larger MSOs are right here, buyers are right here. Everybody’s right here. Everyone seems to be constructing extra develop area. Florida nonetheless stays a really untapped market. We’re nowhere close to saturation on variety of shops, variety of sq. footage of cover area. It’s nonetheless a fast-growing market.

Importantly, the technique of maximizing the present footprint is a brilliant one given the restricted capital necessities and extra capability that the shops can take up. There may be with out query a land seize going down in Florida, however as a share taker, it will be extra helpful for Cansortium to have absolutely stocked cabinets, be shifting stock and ensuring they’re catering to the client base. I can’t overstate the advantages of this as widespread sense will reveal that having sufficient product to promote means…extra gross sales. It additionally means with the ability to push increased margin / increased sale merchandise, run gross sales checks, higher make the most of reductions and improve knowledge assortment. When requested about development charges and SSS as of Q2, administration had this to say:

What you are seeing is simply pure stock. We had been in a position to accomplish this development. This firm, like many others, was stock constrained in 2020 and even in ’21, as a result of stock, as a result of it is vertical and we can not get hold of our merchandise from every other supply, we needed to develop it to promote it. And so what you are seeing within the This fall of ‘21 after which Q1 and Q2 is simply pure biomass coming on-line, these services that we needed to make investments and construct are coming on-line. So we had been in a position to put extra product within the shops. The demand continues to be there. We may proceed to develop in gross sales and would anticipate that we may in our present shops. We have not but reached the saturation level of demand on our present shops. Now, projections on after we’ll attain that, I am not in a position to let you know that, however the truth is that we may proceed to soak up extra stock, even in all probability one other 15%, 20% in our present shops.

Of observe, a fast have a look at IFRS earnings doesn’t precisely paint the image of profitability. Sadly, one quirk of IFRS because it pertains to hashish is that corporations are required to record ‘organic belongings’ on the stability sheet which include hashish vegetation within the develop course of that can in the end be transferred to stock on the market. The belongings are topic to quarterly estimates as there isn’t any lively secondary marketplace for hashish vegetation, and the belongings are valued at truthful worth much less prices to promote which estimates the anticipated harvest yield in grams for vegetation at the moment being cultivated and the anticipated promoting value much less prices to promote. It is a very tough course of to endure, is topic to vital estimates, and might change continuously, leading to recording features or losses on organic belongings. These changes end in what Cansortium reviews as ‘adjusted gross margin’ which is gross revenue plus or minus the modifications in truthful worth of organic belongings, and plus or minus the realized truthful worth of increments on stock offered (mainly the price of manufacturing). I view adjusted gross margin as normalized.

For instance, throughout Q1 2021, a big unrealized acquire in truthful worth of organic belongings was recorded which boosted gross margin, whereas in Q1 2022 the acquire was a lot much less, leading to what seems to be like extreme gross margin compression. It is mainly six a technique, half dozen one other as these fees are both added again or subtracted on the money move assertion. In consequence, it is tough to derive normalized gross margins apart from to say throughout 2021, GMs had been above 60%, and have are available in the identical by the primary two quarters of 2022. I’d estimate these figures to say no barely over time however administration appears assured {that a} >60% GM is an achievable long-term determine. EBITDA margins are equally robust within the 30-35% vary, though changes need to be made which I contact on under.

As Cansortium continues to take share, improve its Florida dispensary depend, and obtain extra income contributions from different states, it wouldn’t be laborious to think about revenues rising at a 30% clip for the following few years. With a powerful model, cultivation buildouts full and minimal capex for brand spanking new dispensaries (mainly lighting, millwork, flooring and so forth.), incremental margins ought to look very engaging and EBITDA move by ought to be very robust. Ought to new dispensaries carry out in step with the present footprint over time and SSS stay wherever close to in the present day’s ranges (mid-teens) then outcomes might be even stronger.

Background

As talked about, Cansortium is considerably of a turnaround story with a shaky previous consisting of over-aggressive growth plans, administration and board modifications, and debt restructuring. Below the management of former co-founder and CEO José Hidalgo, the corporate had formidable plans to almost triple their dispensary footprint in 2019, however fell flat on their faces. Capital necessities, steady building delays and cultivation points led to restricted income technology together with large working losses and money burn. The prior administration workforce additionally entertained the concept of increasing into Puerto Rico and Canada which proved to be ill-fated as managing cultivation, processing, distribution and retail operations in a number of nations with restricted geographical proximity is extremely tough. Convertible debt of $25mm was issued in 2019 and following one other spherical of decreased fiscal yr outlook, value slicing measures had been undertaken in addition to a board and administration shakeup. Three unbiased administrators had been put in (certainly one of which included David Abrams of Harris/Blitzer/Apollo fame), whereas co-founder and Chairman José Hidalgo (moved to Chairman from the CEO position a couple of weeks earlier) resigned together with the COO and VP of Finance. Price cuts had been additionally enacted within the type of workforce reductions and elimination of senior administration personnel and compensation, aiming to save lots of Cansortium round $5mm per yr.

Just a few weeks later, the corporate additionally introduced that it reached an settlement with co-founders José Hidalgo and Henry Batievsky, together with two different former senior executives, for his or her speedy return of greater than 26 million shares of inventory, in combination, representing nearly 15% of Cansortium’s excellent shares on an as-converted foundation. The co-founders agreed to switch these shares for nominal consideration to the corporate for cancellation or to help within the recapitalization of the corporate. Mainly, the board determined that the founders share issuance was overly beneficiant however let the previous administration workforce stroll away with one thing. Following that, on the finish of 2020, Cansortium additionally introduced they entered into agreements to promote each the Canadian and Puerto Rican operations for undisclosed quantities so as to concentrate on Florida and continued US operations.

Cansortium continued by restructuring their debt in early 2020 with $13mm of Promissory Notes being restructured to take away amortization and prolong the maturity, whereas an extra $13mm in near-term liabilities had been paid off utilizing the returned Founder’s shares mentioned above. A capital elevate was carried out a couple of months later through personal placement whereby Cansortium supplied 10.2mm fairness models at $0.45 per unit, or roughly $4.6 million. Every unit consisted of 1 widespread share and one widespread share buy warrant which entitles holders to amass one share at an train value of $0.45 per warrant share.

The turnaround efforts began to bear fruit in Q1 2020 the place Cansortium grew revenues over 80% YoY and generated constructive EBITDA for the primary time within the firm’s historical past. Present CEO Robert Beasley was appointed to the position in September 2020 following a ten-month stint as a Senior Advisor to the Board. I’m a fan of Beasley to this point and contact extra his background under.

Capital Construction

As of this writeup, Cansortium has 252.2 million widespread shares carrying one vote per share, and a couple of.7mm Proportionate voting shares carrying ten votes per share. The choice incentive plan has an extra 16mm choices excellent together with 38mm warrants at a one for one conversion, for a complete of 308mm absolutely diluted shares. The weighted common train value of the choices is $0.52/share, and the warrants have varied strikes, all increased than in the present day’s share value.

Cansortium additionally entered right into a credit score settlement with a syndicate of lenders throughout 2021 offering for a mortgage as much as $71mm. The mortgage matures in 2025 and bears curiosity at 13%, callable in 18 months. The Time period Mortgage consisted of a $50 million tranche priced with an unique situation low cost of three% plus 12.5 million warrants to amass 12.5 million widespread shares with an train value of $1.20 per share for a time period of 4 years after the time limit; in addition to a $21 million tranche priced with an unique situation low cost of seven% with no fairness element. Topic to sure situations, the mortgage will be elevated by as much as $20 million. If nothing else, this financing speaks to the dearth of engaging financing choices within the trade, which aren’t enhancing. I requested about potential refinancing and I feel Cansortium could be involved in exploring all choices. Nevertheless, with charges rising and hashish nonetheless federally unlawful, there aren’t any nice choices in the mean time. Of observe, two former board members (together with David Abrams) participated within the financing. Primarily based on the low finish of CNTMF’s 2022 EBITDA information, leverage is available in at 2.8x.

Lastly, in April of this yr Cansortium accomplished non‐brokered personal placement that features a 10.0% unsecured convertible debenture within the principal quantity of $3mm, in addition to 3,076,923 pre‐funded widespread share buy warrants at a value of $0.39 per Pre‐Funded Warrant, for combination gross proceeds of $4.7mm. The Debenture will come due in 2032 and is convertible into widespread shares at a conversion value of $0.79 per widespread share. Every Pre‐Funded Warrant shall entitle the holder to buy one widespread share at an extra train value of $0.40 per widespread share (for a complete widespread share situation value equal to $0.79) for a interval of 12 months from the date of issuance.

Notes on the Florida Market and Regulation

There are a selection of states that haven’t but legalized medical or grownup hashish use and have positioned heavy restrictions on the quantity of THC in varied merchandise in addition to the situations required for sufferers to acquire medical marijuana (seizures, epilepsy, most cancers, terminal sicknesses). Florida’s foray into medical gross sales started when these bans had been lifted absolutely in 2019 by Governor Ron DeSantis who signed a invoice lifting the ban on the sale of medical marijuana. Texas, as you may think about, is maybe probably the most restrictive state within the US on the subject of hashish and has barely budged on a number of the laws I simply talked about. Right this moment, there are 22 Medical Marijuana Therapy Middle (MMTC) license holders in Florida, liable for tons of of dispensaries throughout the state.

Florida is an outstanding medical use market with over 740,000 registered medical sufferers. The state generated over $1.0 billion in medical gross sales throughout 2020, $1.3 billion in medical gross sales in 2021, and is on tempo for over $1.5 billion throughout 2022. Presently, Florida provides round 150-170k new medical card holders per yr, and with a inhabitants of twenty-two million incorporates inside it a major TAM for each medical and grownup use. The estimated affected person depend represents one thing like 3-4% of Florida’s grownup inhabitants. Trade estimates forecast the Florida market to double in measurement by 2026 and attain practically $3.0B in revenues throughout that point. Trulieve (OTCQX:TCNNF) is an MSO and the main scaled participant in Florida with over 50% market share all through their 100 dispensaries and practically $1.2B in revenues. Curaleaf (OTCPK:CURLF) is a detailed second. Whereas boundaries to entry are comparatively low for the precise building of the retail shops (resulting in the numerous growth you’ve seen amongst practically all MSOs), boundaries for licensing, approvals, permits, and regulatory affairs are fairly excessive from each a time and assets standpoint.

There may be additionally a land seize going down in Florida from each an growth standpoint and retail/market share standpoint within the type of product discounting. Whereas I wouldn’t usually be too excited a few retail race to the underside, I consider its transitory as in the end the best high quality flower, manufacturers and ideas will survive (and must make a margin to exist). As well as, I don’t consider a single state like Florida has a TAM sufficiently big to justify steady loss making comparable to a software program firm with a $100B TAM. The state will rationalize over time, however the land seize standing may also end in consolidation, which I view as a constructive for Cansortium. Trade specialists have additionally claimed that Florida licenses are probably the most useful in the whole trade. It is because every MMTC licensee can open an infinite variety of dispensaries, cultivation and processing services all through the state, a attribute distinctive to the Florida program.

Whereas that could be the case, boundaries stay excessive. Importantly, in 2017, the Florida medical marijuana regulation established a cap on the variety of medical marijuana dispensaries in a position to function throughout the state, whereas additionally requiring that every dispensary be vertically built-in, which means they need to additionally handle cultivation, processing and distribution for the dispensaries. That is probably a kind of silly political guidelines (that has been challenged many occasions however by no means overturned) that can probably fall by the wayside as soon as hashish is de-scheduled and authorized on the Federal degree, opening the doorways for capitalism to come back in and do its factor by chopping up every a part of the availability chain over time. For now, nevertheless, these laws present boundaries to entry by way of capital necessities, along with the authorized, technical and operational expertise wanted to file the paperwork to acquire a license, entry capital to fund a develop operation, or begin to construct a retail footprint. Though Florida has but to legalize the usage of hashish on an grownup use or leisure foundation, I consider it’s only a matter of time till all states comply with down that path.

Lastly, most corporations don’t disclose their retail unit economics, however I perceive them to be stable with four-wall shops estimated to value between a couple of hundred thousand {dollars} as much as one million or so (relying on sq. footage) to construct with the potential to generate $3.5-6mm in annual revenues at 20-30% EBITDA margins. The unit economics enhance additional in case you are vertically built-in, have your personal cultivation and environment friendly strategies of distribution. Federal legalization and interstate commerce will undoubtedly change lots of issues, however for now, geographic benefits inside states are actual.

Administration

Cansortium is led by Robert Beasley who’s an lawyer by commerce and has completed vital work within the hashish area together with serving to early-stage licensees get hold of their licenses and navigate the regulatory panorama. Should you’ve completed work throughout the hashish trade, you’ll have observed that a lot of the administration groups don’t have direct backgrounds in hashish (how are you going to?) however quite have very completely different though sometimes complementary backgrounds and skillsets. I’ve seen robust backgrounds in authorized, funding banking or finance, and numerous retail operators. There are additionally your share of dangerous actors and a few administration groups which are simply filled with it as there are in any new development trade. Beasley has an attention-grabbing background as he mainly helped create the legislative and rulemaking course of in Florida because it pertains to hashish and has additionally designed and constructed a variety of dispensaries giving him a novel angle as an operator. Beasley began a regulation agency in 2001, specializing in industrial litigation and administrative regulation, and in 2015 he grew to become concerned in legislative efforts to deliver medical hashish to Florida. When the primary 5 licenses had been awarded within the state, he acted as a authorized advisor to these license holders and helped join them with capital sources. He ultimately grew to become chair of the board of a kind of corporations, which launched him into an much more lively position within the hashish enterprise. In consequence, he’s each skilled and educated concerning the trade, and in case you hearken to the calls he supplies far more shade round operations and technique than many executives in hashish. I like the best way he’s enthusiastic about the retail enterprise, development in Florida and slowly increasing into different states.

Previous to Robert Beasley, the corporate was run by co-founder José Hidalgo, who struggled to scale the enterprise, couldn’t elevate non-dilutive capital, and didn’t handle by the buildout of the corporate’s aggressive growth plans. Though issues like building delays are tough to plan for, aggressive steering, over-promising and under-delivering led the board to make a change in 2020. A wise transfer, particularly given the numerous alternative within the state of Florida.

I view administration compensation as particularly reasonable and see nothing egregious surrounding base comp or incentive pay. The board is a special story. The bottom director compensation in 2021 was above $200k, with many different board members receiving over $500k in complete compensation. Though the board compensation has modified since the latest administration info round, I might view these degree of compensation as egregious, particularly for a microcap firm on the verge of a turnaround. Put merely, the board wants work, with mainly no retail, operational or hashish expertise (there’s a pharmacist and nuclear scientist on the board), nevertheless it’s considerably telling that they’ve managed to show this enterprise round (albeit because the Florida rising tide lifts all boats) with no deeply skilled board.

One of many board members, William Smith of The Smith Group, owns 1.4mm proportionate voting shares (52% of the category, 6% of the voting rights) in addition to 35.6mm widespread shares (15.8% of the category, 14.1% of the voting rights). His possession/board settlement with the corporate dates again to the corporate’s inception, the place Smith has served as a supply of capital and offered some type of strategic oversight. In attempting to determine who he’s, I requested for an viewers with him which IR balked at. From what I’ve gathered, he based a couple of TV stations (WPAN) in Florida and is a personal investor outdoors of that. Years in the past, following the sale of his TV belongings he was dwelling in Florida and was launched to the previous administration workforce through a good friend who gauged his curiosity in investing in a hashish associated enterprise. Since then, as talked about, he’s been behind lots of the financings you’ll examine within the filings whereas the corporate was making an attempt to scale. Previous to his share possession and previous to his becoming a member of the board he served as an over-paid advisor to Cansortium. Should you learn the ‘Consulting Charges’ part of the administration info round (through the 6/30/22 Administration Data Round), you may see that Invoice Smith has been paid over $3 million {dollars} to this point as a part of varied agreements with the corporate. Nevertheless, he additionally had a hand in bringing Robert Beasley on as CEO, with whom he had a previous relationship whereas Beasley served as a advisor to Cansortium. At a excessive degree, I consider he’s innocent, not concerned in day-to-day operations and extra so figuring out what occurs strategically within the occasion of a possible acquisition, for instance. I have no idea what share of his internet value is tied to his funding in Cansortium. Though future fairness raises are attainable, I’d think about as the corporate’s largest shareholder who has been concerned with this enterprise for years, he’s not extremely involved in diluting his possession stake in a significant means particularly as the corporate has now reached a degree of actual scale and money move positivity. As well as, I wouldn’t view it because the worst factor on the planet to have a considerably everlasting capital, very incentivized massive shareholder right here, particularly whose cash is probably not going wherever within the brief time period.

Notably, an essential a part of Invoice Smith’s share possession entails one thing referred to as an ‘fairness value assure’ or ‘flooring value obligation’. With out entering into the weeds, Smith’s firm, Can Endeavour, offered a mortgage to Cansortium throughout 2018 within the type of a promissory observe. The observe was restructured in 2020, pushing the maturity to the top of 2022 and offering for the issuance of extra widespread shares to Smith. These widespread shares, along with the unique widespread shares issued throughout 2018 in reference to the unique promissory observe are topic to a value flooring of $0.65/share. I’m engaged on getting the precise particulars of the assure (IR was very obscure, administration pushed our name again to subsequent week), however I consider within the occasion the corporate is offered for let’s say $0.30/share, Invoice Smith could be entitled to obtain $0.65/share for his stake. The value assure expires in Could 2023. I perceive the ridiculousness of issuing such a assure, however it’s at the very least attention-grabbing to me given the present share value of $0.17, which sits materially under the fairness value flooring in addition to each single financing transaction entered into by Smith.

Valuation

There may be at the moment a persistent bias towards smaller hashish corporations by way of their valuations in comparison with the most important corporations within the area. A part of the low cost revolves round lack of understanding (as with most microcaps) however I consider the reductions in some circumstances are unwarranted as smaller corporations usually occasions have increased income development, alternatives for margin growth, equal entry to capital and higher aggressive positionings inside their geographies. Check out this very informative chart (as of 8/27) I discovered on Twitter from somebody with the deal with @cashflow_free. I apologize if it is laborious to see, however you may go to his Twitter and discover it. Cansortium sits within the Tier 3 bucket, and issues get attention-grabbing while you have a look at their income development charges, EBITDA margins and valuation in comparison with the remainder of the universe.

*Of observe, it seems to be just like the chart (in addition to the corporate as of Q2) is together with leases as debt for Cansortium, which elevates the enterprise worth. Excluding the leases, I get an EV of $99.4mm.

Utilizing the low finish of this yr’s information for $90-95mm in revenues and $25-28mm in adjusted EBITDA, Cansortium trades for a completely diluted EV/EBITDA of lower than 4.0x. I estimate they will do at the very least $35mm in EBITDA subsequent yr, pushing the valuation down additional to 2.8x. My estimates for subsequent yr embody a dip in income development in addition to some margin compression. I view this as overly conservative given new dispensaries coming on-line, elevated cultivation capability and continued contributions from PA dispensaries. I do know these are usually not nice companies, the regulatory atmosphere is unsure, and the stability sheet isn’t stellar, however I consider Cansortium is mispriced. Common peer multiples for corporations in Tiers 1-4 are not any decrease than 6.7x. All the hashish universe trades at 8.5x. Even excluding probably the most egregiously valued companies inside Tier 3 displays a ten.5x common a number of. Had been Cansortium to commerce even a couple of turns increased to the bottom comp set a number of of 6.5x EBITDA, (utilizing the low finish of Cansortium’s present yr estimates) upside could be vital.

Earlier than I get roasted on the money move assertion, I’d ask readers to attempt to normalize for a much less restrictive value of capital in addition to a normalized tax fee. I do know that’s not totally truthful. However in case you’re not acquainted, at a excessive degree, flower-touching hashish corporations are taxed on gross revenue, unable to deduct regular enterprise bills in step with non-cannabis corporations. In consequence, tax charges vary between 65-75% for many publicly traded hashish corporations, severely impacting money move and, as a aspect observe, additionally creating massive deferred tax liabilities for some as corporations can elect to defer funds. Whereas I don’t consider this funding depends upon favorable regulation to work, I feel it’s considerably unfair to imagine Cansortium (or any hashish firm) must pay 75% tax fee into the foreseeable future. Nevertheless it’s additionally in all probability unfair to provide them credit score for future normalized free money move. However I feel it is essential to notice what is going to occur to the profitability profile of those corporations if federal legalization takes place. Lastly, capex wants are lower than bigger operators as a share of income, and upkeep capex for retail services is low (mainly lighting and millwork inside), which ought to enhance unlevered free money move shifting ahead.

As talked about, unit economics for the dispensaries are usually not disclosed but, I’m engaged on getting them. A few of these companies, even the most important MSOs don’t even hold issues like particular person retailer degree P&Ls which is form of loopy to consider. Conversations with trade operators did reveal the substantial profitability of some dispensaries across the US, though particular person outcomes rely on issues like vertical integration, geography, market development, location and types. The tough math or common (relying on sq. footage) is one thing like 50-60% gross margins, 10% labor, 30% extra opex (lease, provides, overhead). 4 wall margins appear to be robust and with restricted buildout prices for a smaller dispensary $250-500k, fast ramp up intervals and common income per retailer of $2.5-$4mm, payback occasions and money on money returns will be engaging.

Of observe, in December 2020, AYR Wellness, a big MSO, acquired Liberty Well being Providers, a Florida based mostly operator, for $290mm. On the time of the acquisition, Liberty had simply opened their 28^th dispensary with plans for an additional 14 by the top of 2021. Right this moment, Liberty operates 49 dispensaries within the state of Florida. The value paid represented (albeit when sentiment was a lot better) a 94% premium to Liberty’s inventory value on the time of the deal announcement. Breaking down the maths a bit additional, AYR paid over $10mm per dispensary (on the time) or $7.0mm for the total 42 deliberate dispensaries within the state of Florida. On the time of the acquisition, Liberty was doing lower than $60mm in revenues, reflecting a valuation of round 5.0x revenues. AYR additionally had this to say about Liberty’s dispensaries on the M&A name:

“We count on to considerably enhance the dispensaries productiveness in Florida, which at the moment stands at a run fee income of about $2 million a yr, effectively under the highest efficiency on this state at $4 million to $10 million.”

Utilizing the identical math for Cansortium, with 27 dispensaries projected 2022 revenues of $90-95mm, and Florida representing 85% of revenues, every dispensary ought to be doing on common round $3.0-3.3mm in revenues. On the identical 5.0x gross sales a number of, Cansortium inventory would be valued round $1.30 on Florida operations alone. Whereas Cansortium has remedied their stock/product availability points, curiously, Liberty’s shops had been additionally seen as underperforming on the time of the deal on account of product unavailability and develop inefficiencies. Though it’s not precisely apples to apples, and New Jersey is now an adult-use state, a few of AYR’s shops in New Jersey (previous to adult-use) had been doing $10mm per retailer. Simply wild numbers. I now place much more weight on administration’s feedback about maximizing the present retailer footprint with extra stock absorption accessible. That will characterize a possible extra 23% income development simply by rising stock absorption, with out taking over one new buyer or constructing one new retailer. I consider Cansortium ought to be positioned in the identical/related bucket as AYR’s Florida operations, and consider that adult-use gross sales may drive the identical sort of alternative. Moreover, conversations with trade operators additionally revealed that dispensaries can sometimes be valued at round 1.5x revenues. That is an estimate, refers to lots of mother and pops, and has little or no transaction precedents. In different phrases, I’d view 1.5x revenues the value to pay for a struggling operator. Utilizing that math, in an especially conservative situation and as soon as once more not accounting for added Florida development or any of the optionality described under, Cansortium shares could be valued round $0.40/share for the Florida operations alone.

Utilizing the license worth method to valuation can also be considerably illustrative of the potential worth. I’d estimate that Cansortium’s Florida licenses alone ought to be value practically everything of Cansortium’s market cap. I’d estimate a superb baseline to be $75-100 million for the licenses alone. Various precedent transactions, some relationship years in the past, level to Florida vertical integration licenses being value between $50-60mm. Planet 13’s buy of Harvest Well being Florida medical license for $55mm is one instance. Planet 13 has but to start cultivation pointing to the worth of Florida operations being value greater than $55mm over time. Nature’s Approach additionally offered a license in 2019 for $67 million. In late August, Inexperienced Sentry, a personal hashish operator, acquired all of MedMen’s Florida operations for $63 million. Included within the buy value was an MMTC license, 14 dispensaries and a small cultivation facility. As talked about, the Texas license may additionally fetch between $60-80mm as Cansortium is certainly one of solely three licensees in a state that has but to legalize even medical use.

Placing all of it collectively:

Texas license per share @ $60mm: $0.20/share (taken with a grain of salt)

Michigan and Pennsylvania operations / licenses per share @ $28mm: $0.09/share

Florida operations per share @ 6.5x 2023 EBITDA: $0.60/share

(-) Debt: $56mm (excl. op. leases): $0.18/share

(+) Money: $9.0mm: $0.03/share

Fairness Worth (excluding Florida license worth): $0.74/share or 335% upside

Lastly, it’s value mentioning that towards the top of the 2021 Annual Assembly, in the course of the Q&A session, the one query requested was concerning the board’s receipt of a proposal by a enterprise capital agency, Iconoclast Ventures, to amass all of the excellent shares of the corporate. Iconoclast was based by Jake Bergmann (who requested the query), one of many co-founders of Surterra Wellness, the third largest hashish operator within the state of Florida. Given the share value of Cansortium has declined 80% this yr, simply as the corporate has righted the ship and set to expertise vital development and profitability from right here, I seen the potential bid on the time as very opportunistic. As well as, trade conversations revealed that there was no formal supply letter, no financing in place, and considerably unprofessional in presentation. In truth, there was such little substance to the ‘supply’ that it was not materials sufficient to reveal. I solely spotlight it right here as affirmation of the attractiveness of Cansortium’s belongings and aggressive place. I doubt Surterra would be the final takeout supply they obtain.

Last Caveat

All the hashish sector is being pushed by flows and sentiment. It is form of wild. On one hand, I just like the non-correlated a part of issues as these shares do not typically commerce in step with the broader economic system/market (though a recession would clearly damage the buyer), however however, valuations may stay depressed and even dip farther from right here. I feel many buyers ideas SAFE banking and federal legalization would have handed at this stage, and the truth that it hasn’t has led to lots of capital leaving the area, and a few massive hashish funds shutting down. Capital markets have all however dried up as effectively, with capital raises down 66% from 2021 (fairness capital raises down 97%) and M&A quantity down 80% YoY. This has clearly put vital strain on hashish shares – as if there wasn’t already from 2021 – and this yr has been notably brutal. It may stay that means if folks hand over hope fully that SAFE banking will ever cross. One educated investor within the area stated we may expertise a ‘nuclear winter’. If that had been to occur, mixed with an precise extended recession, we may see a wave of bankruptcies as there are already loads of operators who’re struggling below the burden of pricing, growth and debt hundreds (in addition to massive deferred tax funds). In consequence, the largest danger to the thesis entails not seeing any close to time period share value improve, no a number of growth, and no M&A exercise the place Cansortium might be explored as a takeout goal. In a multi-year bearish situation the place SAFE banking would not cross, no capital enters the area, establishments are frozen out and capital markets dry up, I’d doubtless rethink my bullish tone. It is also attainable that some corporations buying and selling at 3x – 4x – 5x EBITDA may see their valuations drop additional, however like several disaster a few of these enterprise can have alternatives to get stronger and proceed to take share. Together with Cansortium, I’ve made it a precedence to concentrate on the operators with respectable stability sheets, money move technology, decrease tax funds, robust manufacturers and situated in nice markets or protected states. In opposition to that backdrop, my biased opinion is that Cansortium would nonetheless function a really robust acquisition candidate which makes it much more attention-grabbing proper now.

Optionality

• Cultivation capability will increase / yield enhancements
• Florida opening up grownup use legalization
• Extra dispensary openings in Florida
• Acquisition supply / takeout
• Texas license being offered
• Extra dispensaries in Pennsylvania
• Sentiment enchancment!

Dangers

• Hassle scaling – mitigated with current efforts
• Federal legalization introduces vital competitors – powerful to keep away from however CNTMF has scale in Florida, and legalization could be the tide that lifts all boats
• Steadiness sheet inflexibility – there will probably be options right here together with elevated time period mortgage and refinancing ultimately
• Potential dilution – I consider dilution is behind them at this stage
• Single state operators don’t obtain increased multiples – don’t want a better a number of for this to work out effectively
• Giant particular person share possession – I don’t consider this will probably be an issue as the person has been concerned for a very long time, is on the board and will need to see a constructive end result
• Competitors – CNTMF is in a protected state and would make for a powerful acquisition goal
• Can’t do something in Texas or something with the license – stays to be seen however administration thinks in any other case